MKNK2 and neoplasm: According to these results, we believe that up-regulation of MNK2 promotes tumor proliferation and metastasis via phosphorylated eIF4E in NSCLC, leading to poorer prognosis, later clinical stage, and higher chance of lymph node metastasis.